Financials
- Market Capitalization 479.54 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2939 | EVMN Evommune, Inc. Common Stock | 13.43 USD | -4.95% | -2.61% | +20.88% | -22.46% | 487.40 M USD | ||
| 2948 | RLMD Relmada Therapeutics, Inc. - Common Stock | 4.52 USD | -0.66% | -3.42% | -13.58% | +444.58% | 482.15 M USD | ||
| 2957 | PBYI Puma Biotechnology Inc - Common Stock | 9.24 USD | +0.87% | -0.22% | +16.08% | +83.70% | 476.97 M USD | ||
| 2962 | AGMB AgomAb Therapeutics NV - ADRs representing one | 13.84 USD | -3.08% | +2.52% | +10.37% | -5.85% | 472.87 M USD |
Frequently asked questions about Rezolute, Inc. Common Stock (NV)
What is the Rezolute, Inc. Common Stock (NV) stock price today?
The current price of Rezolute, Inc. Common Stock (NV) (RZLT) is 4.98. Over the past 24 hours, the stock has changed by -1.19%. Follow the RZLT chart for real-time price dynamics.
What is the stock ticker of Rezolute, Inc. Common Stock (NV)?
Rezolute, Inc. Common Stock (NV) trades under the ticker RZLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rezolute, Inc. Common Stock (NV) stock going up?
RZLT has changed by +6.18% over the last week, +1.01% over the last month, and -31.69% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Rezolute, Inc. Common Stock (NV)?
Rezolute, Inc. Common Stock (NV) currently has a market capitalization of 479.54 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Rezolute, Inc. Common Stock (NV) earnings last quarter?
Last quarter, Rezolute, Inc. Common Stock (NV) reported earnings of -0.16 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Rezolute, Inc. Common Stock (NV) revenue for the last quarter?
Rezolute, Inc. Common Stock (NV) reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Rezolute, Inc. Common Stock (NV) net income for the last quarter?
Rezolute, Inc. Common Stock (NV) reported net income of -16.17 M for the last quarter. The previous quarter showed -22.77 M, which means net income changed by +28.99%.
How many employees does Rezolute, Inc. Common Stock (NV) have?
As of the latest available data, Rezolute, Inc. Common Stock (NV) has 71 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Rezolute, Inc. Common Stock (NV) stock?
You can buy Rezolute, Inc. Common Stock (NV) (RZLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rezolute, Inc. Common Stock (NV) stock?
Investing in Rezolute, Inc. Common Stock (NV) requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RZLT chart and related analysis on metatrader.com as part of your research.